Tamsulosin Hydrochloride
Product Images NDC 16590-298

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 16590-298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Tamsulosin HCl Label 298)

Label Image (Tamsulosin HCl Label 298)
Packaged medication called Tamsulosin, distributed by Wockhardt USA LLC. Each capsule contains 0.4mg of Tamsulosin and is labeled with the NDC code 16590-298-30 and NOC code 64679-516-02. The medication is prescribed to treat urinary problems related to an enlarged prostate gland. The address of the distributor is not available.*
FDA Label Image

Figure1 (Tamsulosin HCl Capsules Figure 1)

FDA Label Image

Figure 2a (Tamsulosin HCl Capsules Figure 2a)

Figure 2a (Tamsulosin HCl Capsules Figure 2a)
This appears to be a graph or table displaying the mean change in some variable based on different treatments and duration of treatment. However, without additional context it is difficult to accurately describe the study or outcome being presented.*
FDA Label Image

Figure 2b (Tamsulosin HCl Capsules Figure 2b)

FDA Label Image

Figure3a (Tamsulosin HCl Capsules Figure 3a)

Figure3a (Tamsulosin HCl Capsules Figure 3a)
This is a graph showing the results of a treatment for a condition, with two groups: one receiving a medication and the other receiving a placebo. The vertical axis shows the quantity of a certain measurement (in mL/sec). The horizontal axis shows the number of weeks of treatment. The results show that the group receiving the medication had an improvement in the measurement compared to the placebo group, with a greater difference as the duration of treatment increased. There were different amounts of people in each group at the different time points (shown in parentheses next to the x-axis values).*
FDA Label Image

Figure3b (Tamsulosin HCl Capsules Figure 3b)

FDA Label Image

Structure (Tamsulosin HCl Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.